JACOBS LEVY EQUITY MANAGEMENT, INC - GLYCOMIMETICS INC ownership

GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 32 filers reported holding GLYCOMIMETICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of GLYCOMIMETICS INC
ValueSharesWeighting
Q3 2021$799,000
+4.7%
365,013
+11.0%
0.01%0.0%
Q2 2021$763,000
-41.9%
328,964
-24.6%
0.01%
-50.0%
Q1 2021$1,314,000
+9.8%
436,541
+37.1%
0.01%0.0%
Q4 2020$1,197,000
+69.3%
318,367
+38.2%
0.01%
+42.9%
Q3 2020$707,000
-35.0%
230,313
-20.3%
0.01%
-41.7%
Q2 2020$1,087,000
+457.4%
289,104
+237.9%
0.01%
+300.0%
Q1 2020$195,000
-33.4%
85,552
+54.5%
0.00%0.0%
Q4 2019$293,000
+150.4%
55,362
+188.3%
0.00%
+50.0%
Q4 2016$117,000
-38.4%
19,200
-27.7%
0.00%
-33.3%
Q3 2016$190,000
-8.7%
26,565
-7.3%
0.00%
-25.0%
Q2 2016$208,000
+28.4%
28,665
+5.1%
0.00%
+33.3%
Q1 2016$162,000
+1.2%
27,265
-2.3%
0.00%0.0%
Q4 2015$160,000
+61.6%
27,909
+58.6%
0.00%
+50.0%
Q3 2015$99,000
-58.1%
17,599
-40.7%
0.00%
-50.0%
Q2 2015$236,00029,6700.00%
Other shareholders
GLYCOMIMETICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,000,000$5,220,0000.73%
NEA Management Company, LLC 4,764,440$8,290,1260.63%
Artal Group S.A. 8,589,064$14,9450.46%
BVF INC/IL 9,544,262$16,607,0160.46%
Sargent Investment Group, LLC 108,000$187,9200.05%
Intellectus Partners, LLC 73,475$127,8470.04%
XTX Topco Ltd 29,998$52,1970.01%
AXA S.A. 1,631,509$2,838,8260.01%
ACADIAN ASSET MANAGEMENT LLC 1,149,656$1,9990.01%
TOBIAS FINANCIAL ADVISORS, INC. 15,000$26,1000.01%
View complete list of GLYCOMIMETICS INC shareholders